IRMD - iRadimed Non-GAAP EPS of $0.36 beats by $0.06 revenue of $16.13M beats by $0.47M
2023-08-03 08:27:12 ET
- iRadimed press release ( NASDAQ: IRMD ): Q2 Non-GAAP EPS of $0.36 beats by $0.06 .
- Revenue of $16.13M (+26.8% Y/Y) beats by $0.47M .
- For the third quarter of 2023, the Company expects to report revenue of $16.1 million to $16.3 million, GAAP diluted earnings per share of $0.33 to $0.35, and non-GAAP diluted earnings per share of $0.36 to $0.38.
-
For the full-year 2023 financial guidance the Company now expects to report revenue of $64.5 million to $65.5 million, GAAP diluted earnings per share of $1.25 to $1.28, and non-GAAP diluted earnings per share of $1.37 to $1.40.
For further details see:
iRadimed Non-GAAP EPS of $0.36 beats by $0.06, revenue of $16.13M beats by $0.47M